DarioHealth Corp.
DRIO
$0.666
-$0.0315-4.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.03M | 27.04M | 23.05M | 19.15M | 19.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.03M | 27.04M | 23.05M | 19.15M | 19.04M |
| Cost of Revenue | 8.58M | 8.75M | 9.01M | 8.61M | 9.33M |
| Gross Profit | 19.46M | 18.30M | 14.04M | 10.54M | 9.72M |
| SG&A Expenses | 41.64M | 46.10M | 46.27M | 46.30M | 45.03M |
| Depreciation & Amortization | 4.74M | 5.03M | 4.85M | 4.61M | 4.47M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.60M | 84.06M | 83.22M | 82.83M | 80.55M |
| Operating Income | -48.57M | -57.02M | -60.16M | -63.68M | -61.51M |
| Income Before Tax | -44.64M | -44.60M | -49.34M | -52.73M | -55.71M |
| Income Tax Expenses | 164.00K | -1.85M | -1.94M | -1.93M | -1.93M |
| Earnings from Continuing Operations | -44.80 | -42.75 | -47.40 | -50.80 | -53.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.80M | -42.75M | -47.40M | -50.80M | -53.78M |
| EBIT | -48.57M | -57.02M | -60.16M | -63.68M | -61.51M |
| EBITDA | -41.21M | -49.59M | -53.97M | -57.96M | -56.41M |
| EPS Basic | -0.60 | -0.65 | -0.95 | -1.19 | -1.69 |
| Normalized Basic EPS | -0.60 | -0.64 | -0.88 | -1.03 | -1.18 |
| EPS Diluted | -0.60 | -0.66 | -0.95 | -1.19 | -1.69 |
| Normalized Diluted EPS | -0.60 | -0.64 | -0.88 | -1.03 | -1.18 |
| Average Basic Shares Outstanding | 206.50M | 193.57M | 143.59M | 131.99M | 120.35M |
| Average Diluted Shares Outstanding | 206.50M | 193.57M | 143.59M | 131.99M | 120.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |